Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias

Department of Medicine, University of California, San Francisco 94143-0214.

Efficacy, side effects and predictors of response for intravenous amiodarone were evaluated in 46 patients with recurrent drug-refractory sustained ventricular tachycardia or ventricular fibrillation, or both, who were treated with intravenous amiodarone. Of the 46 patients, 27 (58.5%) responded early to intravenous amiodarone and 6 (13%) showed a late response to amiodarone. The majority of patients who responded to intravenous amiodarone did so within the first 2 h of therapy, and all responded within 84 h. Patients with an ejection fraction greater than 25% were more likely to respond (p less than 0.05). Major side effects occurred in 13% of patients. The cumulative 2 year mortality rate due to arrhythmia recurrence or sudden death for responders discharged from the hospital was 23% and the cumulative overall 2 year mortality rate was 46%. In conclusion, intravenous amiodarone is rapidly effective in the majority of patients with recurrent ventricular tachycardia or ventricular fibrillation refractory to other drugs. The poor long-term outcome of patients who require this therapy, respond to it and are discharged on long-term oral amiodarone therapy warrants consideration of other long-term treatment of these patients. Use of intravenous amiodarone is an important new modality in the treatment of drug-refractory malignant ventricular arrhythmias.

This article has been cited by other articles:

				L. J. Morrison, C. D. Deakin, P. T. Morley, C. W. Callaway, R. E. Kerber, S. L. Kronick, E. J. Lavonas, M. S. Link, R. W. Neumar, C. W. Otto, et al. Part 8: Advanced Life Support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Circulation, October 19, 2010; 122(16_suppl_2): S345 - S421. [Full Text] [PDF]

				D. J. Cushing, M. P. Adams, W. D. Cooper, P. R. Kowey, and R. J. Lipicky Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants J. Clin. Pharmacol., April 1, 2009; 49(4): 407 - 415. [Abstract] [Full Text] [PDF]

				P. Vassallo and R. G. Trohman Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications JAMA, September 19, 2007; 298(11): 1312 - 1322. [Abstract] [Full Text] [PDF]

				Part 4: Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54. [Full Text] [PDF]

				P. R. Kowey, J. H. Levine, J. M. Herre, A. Pacifico, B. D. Lindsay, V. J. Plumb, D. L. Janosik, H. A. Kopelman, and M. M. Scheinman Randomized, Double-Blind Comparison of Intravenous Amiodarone and Bretylium in the Treatment of Patients With Recurrent, Hemodynamically Destabilizing Ventricular Tachycardia or Fibrillation Circulation, December 1, 1995; 92(11): 3255 - 3263. [Abstract] [Full Text]

				M. M. Scheinman, J. H. Levine, D. S. Cannom, T. Friehling, H. A. Kopelman, D. A. Chilson, E. V. Platia, D. J. Wilber, and P. R. Kowey Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias Circulation, December 1, 1995; 92(11): 3264 - 3272. [Abstract] [Full Text]

				X.-J. Du, M. D. Esler, and A. M. Dart Sympatholytic Action of Intravenous Amiodarone in the Rat Heart Circulation, January 15, 1995; 91(2): 462 - 470. [Abstract] [Full Text]

				P K Mazeika Grand Rounds - Hammersmith Hospital: Complicated myocardial infarction Ventricular septal rupture is a surgical emergency BMJ, March 5, 1994; 308(6929): 643 - 645. [Full Text]

				A. Rosalion, N. J. Snow, T. P. Horrigan, D. L. Noon, and N. D. Mostow Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs Ann. Thorac. Surg., January 1, 1991; 51(1): 81 - 85. [Abstract] [PDF]

				J. M. Gore and J. E. Dalen Cardiovascular Disease JAMA, May 16, 1990; 263(19): 2629 - 2631. [Abstract] [PDF]

				M. L. Williams, A. Woelfel, W. E. Cascio, R. J. Simpson Jr., L. S. Gettes, and J. R. Foster Intravenous Amiodarone during Prolonged Resuscitation from Cardiac Arrest Ann Intern Med, May 15, 1989; 110(10): 839 - 842. [Abstract] [PDF]

				INTRAVENOUS AMIODARONE EFFECTIVE AS EMERGENCY THERAPY Journal Watch (General), October 7, 1988; 1988(1007): 1 - 1. [Full Text]